FDA Approves Imaging Drug to Evaluate for Myocardial Ischemia and Infarction
The FDA has approved a radioactive diagnostic drug to evaluate myocardial ischemia and infarction in adults with known or suspected coronary artery disease.
Read MoreThe FDA has approved a radioactive diagnostic drug to evaluate myocardial ischemia and infarction in adults with known or suspected coronary artery disease.
Read MoreA study of over 7.7 million children found that heart defects were around 36% more common in babies born after assisted reproduction.
Read MoreThe proportion of younger heart failure patients aged 35-64 is rising, with mortality increasing faster in this group compared to older adults.
Read MoreMetals in the body from environmental pollutants are associated with the progression of harmful plaque buildup in the arteries.
Read MoreSurprisingly, researchers found that those who quit smoking during the study had an 18% lower risk of AFib than people who smoked.
Read More